中医药治疗IgA肾病临床随机对照试验文献

摘要

Objective To explore the method of traditional Chinese medicine in the treatment of IgA nephropathy clinical randomized controled trials and evaluation.Methods From 2004 to 2014, Chinese biomedical journals published in the literature of traditional Chinese medicine and the treatment of IgA nephropathy clinical randomized controled trial of 90.Results 90 pieces of traditional Chinese medicine in treating IgA nephropathy clinical randomized controled trials, single diagnostic criteria 22 articles (24.44%), literature is not clear diagnostic criteria 31 articles (34.44%), clear the inclusion criteria, 13 (14.44%) clear exclusion criteria 14 articles (15.56%), with statistical significance of various types of comparison,P < 0.05. Conclusion In the clinical treatment of IgA nephropathy should be chosen in a large number of experimental literature, the literature is faced with the problem of clinical randomized controled experimental design is not tight, the blind use of low rate, exit and lost report cases of TCM syndrome classification standard is not enough.%目的：探讨中医药治疗IgA肾病临床随机对照试验文献的方法及评价。方法选取2004年到2014年我国生物医学期刊发表的与中医药治疗IgA肾病临床随机对照试验文献90篇。结果90篇中医药治疗IgA肾病临床随机对照试验文献中，单列诊断标准项22篇（24.44%），文献没有明确诊断标准31篇（34.44%），明确文献纳入标准13（14.44%），明确排除标准14篇（15.56%）等等，各类型对比具有统计学意义， P <0.05。结论临床上在治疗IgA肾病时必须选用大量实验文献，实验文献的使用面临着临床随机对照实验设计不严密、盲目使用率偏低、病例退出和失访报道不够中医症候分类不规范等问题。